Gain Therapeutics (GANX) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Gain Therapeutics (GANX) over the last 6 years, with Q3 2025 value amounting to -$251654.0.
- Gain Therapeutics' Other Gross PP&E Adjustments fell 52429.67% to -$251654.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$251654.0, marking a year-over-year decrease of 52429.67%. This contributed to the annual value of -$454705.0 for FY2024, which is 2889.57% up from last year.
- As of Q3 2025, Gain Therapeutics' Other Gross PP&E Adjustments stood at -$251654.0, which was down 52429.67% from -$400220.0 recorded in Q2 2025.
- In the past 5 years, Gain Therapeutics' Other Gross PP&E Adjustments ranged from a high of -$40310.0 in Q3 2024 and a low of -$1.0 million during Q4 2021
- Over the past 5 years, Gain Therapeutics' median Other Gross PP&E Adjustments value was -$454705.0 (recorded in 2024), while the average stood at -$476794.2.
- Per our database at Business Quant, Gain Therapeutics' Other Gross PP&E Adjustments soared by 8583.04% in 2024 and then plummeted by 52429.67% in 2025.
- Gain Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$1.0 million in 2021, then skyrocketed by 30.88% to -$705062.0 in 2022, then grew by 9.3% to -$639490.0 in 2023, then increased by 28.9% to -$454705.0 in 2024, then soared by 44.66% to -$251654.0 in 2025.
- Its Other Gross PP&E Adjustments was -$251654.0 in Q3 2025, compared to -$400220.0 in Q2 2025 and -$477108.0 in Q1 2025.